Published: 14 November 2026. Sources read: 14 November 2026. Next check: 14 November 2027.
What the 13 December 2023 joint statement says
On 13 December 2023, the British Association of Hair Restoration Surgery, the British Association of Aesthetic Plastic Surgeons, the British Association of Plastic, Reconstructive and Aesthetic Surgeons, and the Turkish Society of Plastic, Reconstructive and Aesthetic Surgeons issued a joint statement on minimum standards of patient care before and after hair transplant surgery.
The statement supports the position of the British Association of Hair Restoration Surgery that transplantation for male and female pattern hair loss treats a diagnosable condition that is genetically caused and hormonally mediated. It says that, in most cases, this should not be treated as cosmetic surgery. Its immediate audience is UK residents considering travel to Turkiye, against a stated rise in travel abroad for the procedure. The questions below are nevertheless usable wherever surgery is proposed, including within the UK, because they concern who plans and performs the operation, how consent is handled, and what happens afterwards.
The four bodies say risk is lower where the doctor who will carry out the surgery agrees and plans it in advance, and where surgical steps are performed by a doctor rather than a technician. They identify appearance-related complications as the more common type. The statement does not provide outcome rates, comparative procedure data, or a method for choosing between harvesting techniques.
The source material is published as news pages by the British Association of Plastic, Reconstructive and Aesthetic Surgeons and the British Association of Aesthetic Plastic Surgeons. As read on 14 November 2026, neither publisher's page offered a downloadable version of the full joint statement. This article therefore reports the five points published on those pages, rather than presenting an unseen underlying document as though it were available to readers.
| Evidence Position | Assessment | What would change it |
|---|---|---|
| Published position | Four membership associations set out five minimum-care points for hair transplant surgery. | A fuller jointly published document could add context, definitions or further standards. |
| Regulatory status | The statement is not legislation and has no statutory force. | A statutory rule or regulator-issued requirement would have a different status. |
| Use of this checklist | Plausible as a consultation prompt because it follows the published points. | It should not be mistaken for an individual clinical assessment. |
The seven questions to ask out loud
The seven questions below are this publication's wording of the five published points. They are not the associations' own list of questions. They are designed to make the proposed division of responsibility clear before a person commits to surgery. A provider may answer some elements in writing, but the useful test is whether the answer identifies named roles and a defined process rather than relying on general assurances.
- Who assesses me, and will that same doctor operate on me?
- Who makes the skin incisions, and will a technician make any of them?
- How many follicular units are proposed, how was that number arrived at, and what is left in the donor area?
- What is proposed for the hair I still have?
- When am I asked to pay, and do I get the two weeks the joint statement asks for?
- Who assesses interim progress and the final result, and who do I call outside working hours?
- What would make you advise against operating on me at all?
Questions one, two, five and most of six map directly to the published points. Question three combines the statement's requirement that the operating doctor decide the harvesting method and the number of follicular units or hairs required with a further practical question about the donor area. Question four is a prompt about retained hair, not a quoted standard in the statement. Question seven is also not a published standard. It is a judgement question, included because a consultation should be able to identify circumstances in which surgery is not advised.
For related background before restoration is considered, read this publication's further reading, Hair loss assessment: what it should establish before restoration. That separate reference concerns assessment; this page concerns surgical responsibility, travel and arrangements around the operation.
Who assesses you and who performs the operation
The joint statement's first point is specific: consultation should be with the doctor who will perform the surgery. That doctor should decide the donor-hair harvesting method, the number of follicular units or hairs required, and the hairline and transplant design. This is why the first question asks both who conducts the assessment and whether that person will operate. A consultation conducted by one person and an operation performed by another is not, by itself, enough information to show whether the published expectation has been met.
The second published point of responsibility concerns skin incisions. The statement says that if a doctor will not make the incisions to harvest or implant the hair, the patient must be told explicitly at the initial consultation, including whether a technician will make them. The wording matters. Asking only whether a doctor will be present does not establish which steps that doctor will undertake, which steps another person will undertake, or whether the allocation was disclosed at the outset.
Question three adds detail to the first point. The statement refers to the number of follicular units or hairs required, and to the harvesting method, as decisions for the operating doctor. It does not set a universal number, prescribe one method, or define what amount should remain in a donor area. Those depend on an individual surgical proposal and cannot be supplied by this checklist. The question asks for the reasoning so that the proposed number is not detached from the stated design and harvesting plan.
Question four, about hair that remains, goes beyond the statement. It is included as a practical continuity question, not as an association requirement. It should not be treated as evidence that any particular plan is suitable.
Consent, payment and the two-week consideration period
The joint statement says a patient should be given two weeks to consider the recommendation and proposed consent form before paying anything for surgery. This is the basis for question five. The point is not simply whether papers are supplied. It is whether the recommendation and proposed consent form are available with enough time for the person considering surgery to read them before any payment is requested.
The statement does not explain every possible payment arrangement, define what counts as a proposed consent form, or state how a dispute about timing should be resolved. It does, however, give a clear minimum expectation that can be asked about directly. A patient can ask when payment is requested, when the recommendation will be supplied, when the consent form will be supplied, and whether two weeks are available between receiving those materials and paying for surgery.
This is especially relevant where a consultation, travel planning and an operation are arranged close together. The statement is addressed to UK residents considering travel to Turkiye, but the logic of the question is not geographically confined. A short interval can make it harder to separate a clinical recommendation from the administrative pressure of an itinerary. That is an observation about the decision sequence, not a claim that a particular interval determines the quality of care.
The checklist is not a substitute for reading a consent form or seeking individual clinical advice. Nor does it establish whether a person has understood the information supplied. Its narrower function is to record whether the provider offers the two-week period described by the four associations and whether the operating doctor's proposed role is clear before payment.
Follow-up, complications and contact outside working hours
The fourth and fifth points in the joint statement concern what happens after surgery. The operating doctor should assess interim progress and the final result. The patient should be able to raise grievances, and there should be a clear complaints process. Separately, the clinic should have systems for dealing with complications during and outside working hours.
The statement names skin necrosis, infection, cysts and dysaesthesia among the matters those systems should be able to address, and includes the supplying of antibiotics. It does not say that these events will occur, estimate their frequency, or set out a universal treatment pathway. The appropriate question is therefore not whether complications are impossible. It is who assesses a concern, how contact is made outside ordinary hours, and what process exists if the patient wishes to raise a grievance.
Question six deliberately joins interim review, final assessment and out-of-hours contact. These are connected but distinct arrangements. A provider can identify a follow-up appointment without explaining who makes a clinical assessment. It can provide a daytime contact route without describing what happens outside working hours. It can describe a response pathway without identifying whether the operating doctor is involved. Asking each part separately reduces the chance that a broad answer obscures a missing arrangement.
The statement does not prescribe the format of a complaints process or identify an external body that must receive every complaint. It says there should be a clear process. A patient can therefore ask for the process to be explained before surgery, including who receives the complaint, who responds and whether the operating doctor assesses the concern.
Travel, recourse and the limit of UK reporting routes
The joint statement is specifically framed around UK residents travelling to Turkiye. Its relevance is not that all overseas arrangements are the same, nor that all UK arrangements provide identical recourse. Its reported concern is that travel can change the practical route for follow-up and grievances when surgery has taken place away from home.
Chris D'Souza, then President of the British Association of Hair Restoration Surgery, is quoted on both association news pages as saying that, in the UK, suboptimal care including inappropriate delegation of surgery can be reported to the General Medical Council. He also says an unregistered clinic can be reported to the Care Quality Commission or the devolved equivalent. He contrasts this with other countries, where this is not always the case. This is a recourse point reported from the joint-statement coverage, not a claim that a complaint will produce a particular outcome.
Before travelling, question six should be adapted into practical detail: who is the contact once the patient has returned home, which clinician can assess a concern, and what complaints route exists if the response is disputed? The joint statement supports asking these questions, but it does not map every jurisdiction's law, licensing framework, insurance arrangements or complaint bodies.
Nothing here is a directory of providers or an assessment of any individual service. It does not advise where to have surgery, whether to travel, or whether a particular provider meets the statement. The point is narrower: a patient should be able to identify the operating doctor, delegation of incision-making, time to consider consent, follow-up arrangements and routes for raising a concern.
Reference checklist: record the answer before deciding
This is a reference checklist, not a scoring tool. A complete-looking set of answers cannot establish that surgery is appropriate, that a provider will meet the stated arrangements, or that a result will meet expectations. It can, however, preserve the specific answers given before an operation is arranged. Record answers in the provider's own terms and retain any documents supplied.
| Question | What the 2023 statement supports | What is additional judgement or detail |
|---|---|---|
| Who assesses me, and will that person operate? | Consultation with the doctor who will perform surgery. | Recording the name and role given. |
| Who makes incisions, and will a technician make any? | Explicit disclosure at initial consultation if the doctor will not make harvesting or implantation incisions. | Asking for each role to be described. |
| How many units are proposed, why, and what remains in the donor area? | The operating doctor decides harvesting method and number of follicular units or hairs required. | Questioning donor-area reasoning. |
| What is proposed for my remaining hair? | No direct published point. | A continuity question. |
| When do I pay, and do I have two weeks? | Two weeks to consider recommendation and proposed consent form before paying anything. | Recording dates materials are received. |
| Who reviews progress and handles out-of-hours concerns? | Operating-doctor assessment, complaints process and systems for complications inside and outside working hours. | Recording contact names and routes. |
| What would make you advise against surgery? | No direct published point. | A judgement question, not a published standard. |
A useful decision rule is: if the provider cannot state who will make the operative decisions, who will make the incisions, when the consent material will be available, and who handles concerns outside working hours, do not treat the checklist as completed. This is not a verdict on that provider. It is a rule for distinguishing an answer from an unresolved question.
Limits, reproduction notice and source record
This page does not cover diagnosis of hair loss, medical suitability for surgery, surgical techniques, anaesthesia, medicines, infection prevention, result duration, likelihood of complications, or how a procedure performs. It does not apply a legal or regulatory test to a particular provider. It does not establish whether a clinic is registered, whether an individual is licensed, or which body has jurisdiction in a given place. Those questions require current, location-specific checking and, where needed, individual professional advice.
The 2023 statement is a position statement from four membership bodies. It is not binding regulation and has no statutory force. It is addressed to UK residents considering travel to Turkiye. This page applies its questions more broadly because the questions concern basic allocation of surgical responsibility and aftercare arrangements, but that broader use should not be read as an extension of the statement's legal reach.
The source record for this reporting is the 13 December 2023 joint-statement coverage published by the British Association of Plastic, Reconstructive and Aesthetic Surgeons and the British Association of Aesthetic Plastic Surgeons, read on 14 November 2026. Neither source page, as read on that date, provided a downloadable full text. The reported five points are reproduced here in substance and in their published order; the seven spoken questions are this publication's adaptation.
The seven questions may be reproduced in full by a patient organisation, charity or clinic with a credit to The Aesthetic Journal and a link to this page. Reproduction does not permit presenting the questions as the associations' own wording or as statutory requirements.